0001493152-23-024107.txt : 20230710
0001493152-23-024107.hdr.sgml : 20230710
20230710154744
ACCESSION NUMBER: 0001493152-23-024107
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230410
FILED AS OF DATE: 20230710
DATE AS OF CHANGE: 20230710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: He Junli
CENTRAL INDEX KEY: 0001728598
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35853
FILM NUMBER: 231079698
MAIL ADDRESS:
STREET 1: C/O NO.1, COUNTRY GARDEN ROAD
STREET 2: BEIJIAO TOWN, SHUNDE DISTRICT
CITY: FOSHAN
STATE: F4
ZIP: 528300
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biostage, Inc.
CENTRAL INDEX KEY: 0001563665
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 455210462
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
STREET 2: SUITE 11
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: (774) 233-7300
MAIL ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
STREET 2: SUITE 11
CITY: HOLLISTON
STATE: MA
ZIP: 01746
FORMER COMPANY:
FORMER CONFORMED NAME: Harvard Apparatus Regenerative Technology, Inc.
DATE OF NAME CHANGE: 20121204
4/A
1
ownership.xml
X0407
4/A
2023-04-10
2023-04-12
0
0001563665
Biostage, Inc.
BSTG
0001728598
He Junli
C/O BIOSTAGE, INC.,
84 OCTOBER HILL ROAD, SUITE 11
HOLLISTON,
MA
01746
1
1
0
0
CEO
0
Stock Option (right to buy)
6.08
2023-04-10
4
A
0
267616
0
A
2033-04-10
Common Stock, par value $0.01 per share
267616
267616
D
On April 12, 2023, the Reporting Person filed a Form 4 (the "Original Form 4"), which noted a stock option (right to buy) of 488,256 shares (also known as milestone options) of Biostage, Inc. On July 10, 2023, the Issuer and Reporting Person amended and corrected such option amount to 267,616 shares. This amendment is being filed to amend and restate the reporting of those stock options to report the corrected amount. Subject to continued employment or service through the applicable vesting dates, up to 267,616 shall vest in two increments, each for 133,808 shares, each such vesting subject to certain performance milestones set by the Board of Directors of the Issuer.
/s/ Joseph Damasio, by power of attorney
2023-07-10